戻る Agenda
SESSION 4 : Panel Discussion
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Eri Sekine
Executive Vice President
CMIC Group, Japan
Speaker(s)
Gerard Ong
Singapore
Regional Director, Strategy & Business Transformation
Kyung-Sang Yu, MD, PhD
Seoul National University , Korea, Republic of
Professor, Department of Clinical Pharmacology,
Toshihiko Doi, MD, PhD
National Cancer Center Hospital East, Japan
Deputy Director / Chief, Experimental Therapeutics
Mika Ogasawara
Pfizer R&D Japan G.K., Japan
Data Quality Lead, Biometrics and Data Management
Satoshi Umehara
NTT DATA Corporation, Japan
Manager, Digital Welfare Division, Second Public Sector
Craig Anderson
Pfizer Inc , Canada
Director, R&D Labeling Lead, International Labeling
Anne Moen, PhD, MSc, RN
University of Oslo, Norway
Professor, Faculty of Medicine, Coordinator, Gravitate-Health
Yoshihiro Aoyagi, MS
National Cancer Center Hospital East, Japan
Manager, Department of Medical Information
Arisa Toyoda
Ministry of Health, Labour and Welfare, Japan
Pharmaceutical Safety Division, Pharmaceutical Safety
Yuan Meng
I-Mab Biopharma , China
Head of Medical Office R&D